Our results indicate that after paclitaxel withdrawal, breast cancer cells produce inflammatory cytokines to activate both Wnt/β-catenin and NF-κB signaling pathways which in turn further promote cytokine production from breast cancer cells (Figures 1, 2 and 3). Here, NFKB1 is linked to breast carcinoma.